QLYS: Recent Execution Strength Will Likely Fail To Justify Rich Pricing

Analysts have raised their fair value estimate for Qualys from $110.71 to $117.00, citing recent upward price target revisions, solid Q3 execution with accelerating billings and record operating margins, and five consecutive quarters of guidance outperformance that support expectations for a stronger growth outlook.

Analyst Commentary

Recent commentary has shifted from outright skepticism to a more balanced, wait and see stance. The upgrade to a neutral rating, along with a higher price target of $135 from $115, reflects recognition of solid Q3 execution, including accelerating billings growth, record operating margins, and five straight quarters of guidance outperformance. At the same time, the neutral stance signals that some analysts see the current valuation as more fairly reflecting these strengths, rather than offering clear upside.

Even with a higher fair value and price target, cautious voices are still focused on how sustainable the recent execution will be and whether the growth outlook embedded in current expectations is achievable over time. For you as an investor, that mix of recognition and restraint is important context when thinking about risk and reward.

Bearish Takeaways

• Bearish analysts view the shift to a neutral rating, rather than a more positive stance, as a sign that recent strength in billings and margins may already be reflected in the share price, limiting room for valuation expansion if growth normalizes.
• The move in the price target to $135 from $115, while constructive, is framed by cautious sentiment that depends on continued solid execution, which creates risk if future quarters do not match the recent pattern of guidance outperformance.
• Some bearish analysts highlight that expectations for a better growth outlook are now more central to the thesis, which introduces downside risk if billings or margins lose momentum or if competitive pressures require higher investment.
• The neutral stance itself signals lingering concern that the balance between execution quality and growth expectations is finely poised, so any setback on operating performance could lead to renewed pressure on the shares.

What's in the News

• Qualys provided earnings guidance for Q4 2025, with expected revenues of US$172.0m to US$174.0m and GAAP EPS of US$1.26 to US$1.33, based on an assumed 22% tax rate and about 36.0m diluted shares.
• The company raised full year 2025 guidance, now expecting revenues of US$665.8m to US$667.8m and GAAP EPS of US$5.23 to US$5.30, compared with a prior revenue range of US$656.0m to US$662.0m and EPS of US$4.47 to US$4.77.
• Qualys reported that between July 1, 2025 and September 30, 2025 it repurchased 365,513 shares for US$49.44m and has now completed buybacks totaling 10,384,802 shares for US$1.1947b under the program announced on February 12, 2018.
• The U.S. administration is reported to be considering ways to involve private companies in cyberwarfare efforts, highlighting the policy focus on cybersecurity where vendors such as Qualys operate (New York Times).

Valuation Changes

• The Fair Value Estimate has risen slightly, moving from US$110.71 to US$117.00.
• The Discount Rate has edged down, shifting from 8.46% to about 8.44%.
• The Revenue Growth assumption has increased from roughly 6.35% to about 7.80%.
• The Net Profit Margin assumption is essentially unchanged, moving from about 25.32% to roughly 25.21%.
• The future P/E multiple has ticked up modestly, from about 24.14x to roughly 24.59x.